1223 / Active pharmacovigilance project for reporting suspected Adverse Drug Reactions in the Emergency Department

ITALY
Classification of the PSP
Type of Patient Safety Practice Safe
 
Clinical Risk Management Practice (CRMP)
Related practices from PaSQ database
"Best fit" category of the reported practice
Implementation of Patient Safety initiatives / Activities
There is no specified text here There is no specified text here
Topic of the reported practice
Patient safety system
Aim and the benefit of the Patient Safety Practice
 
The Emergency Department (ED) is a preferred observatory for the detection and monitoring of adverse drug reactions (ADRs) that occur at local level. However, the features of emergency service and the simultaneous management of multiple cases can determine an under-reporting of ADRs. In order to overcome this problem, a project of active pharmacovigilance (PV) - "Epidemiological Monitoring of adverse drug reactions and events in ED" (MEREAFaPS) - was launched in 2006 in Lombardy. The main purpose of the project was to analyze the admissions to the ED that can be attributed to ADRs by assessing the type, frequency, pharmacological classes and involved population. Furthermore, the project aimed at raising awareness about ADRs and the pharmacovigilance reporting system among ED healthcare staff.
Description of the Patient Safety Practice
 
The MEREAFaPS project requires the presence of a pharmacist acting as a “facilitator”, who works with the ED physician for the collection and recording of ADRs. The Emilia-Romagna region joined the project in 2011 by involving eight healthcare organizations in Parma, Piacenza, Modena, Bologna, Forli, Reggio Emilia and Ferrara (coordinating centre). The regional group sets a value of 2,4 suspected ADR reports per 1000 admissions to the ED as the gold standard. At the University Hospital of Parma, the project started on 8th November 2011 coordinated by the Structure of Clinical Governance, Risk Management, Quality and Accreditation. The initial phase consisted in the preparation of the IT tools necessary for reporting and healthcare staff training through dedicated events and the distribution of an information leaflet. The subsequent phase of collection of ADRs reporting started on 20th September 2012. In the reporting phase, the ED physician assesses whether the patient has been admitted to the ED because of a suspected ADR and informs the “facilitator” pharmacist using the IT reporting tool. The pharmacist fills in the ADR reporting form by analyzing the discharge letter, any specialist consult and, in case of hospitalization, the patient medical record. Once the reporting form is complete, the person in charge of the Pharmacovigilance project send it into the National Pharmacovigilance Network (RNF). Staff meetings are periodically organized in order to describe and comment the collected ADR reports.
During the analyzed period, approximately 2,2 ADR reports / 1000 admissions were collected. Even if the gold standard (2,4) has not been reached, the results show the effectiveness of the collaboration between the Clinical Governance Structure, the Pharmacy Service and the ED Unit, since there were no ADR reports from the ED Unit before the project started. This project underlines the key role of the Emergency Department in pharmacovigilance and the importance of the “facilitator” in order to achieve an optimal ADR detection and reporting.
Attachment of relevant written information and/or photos, as appropriate
There is no specified text here
There is no specified text here
There is no specified text here
There is no specified text here
Effectiveness of the Patient Safety Practice
 
Degree of implementation of reported practice
Yes, fully
Level of implementation of reported practice
Unit or ward level
Specific and measurable outcome for the reported practice were defined
Yes
A baseline measurement before implementation of the reported practice was obtained
Yes
A measurement after full implementation of the reported practice was obtained
Yes
Evaluation of a "positive" effect of the reported practice on Patient Safety
The evaluation showed improvements in Patient Safety outcomes
Type of before-and after evaluation
Both/mixed (qualitative and quantitative)
Enclosure of a reference or attachment in case of published evaluation's results
There is no specified text here
There is no specified text here
Health care context where the Patient Safety Practices was implemented
 
Hospital
Transferability
 
Successful implementation of this Patient Safety Practice in other health care settings than above stated
Yes
Specification of implementation in another health care setting(s)
Not known
Successful implementation's level  of this Patient Safety Practice across settings
Yes, across multiple local/national health systems
Involved health care staff
 
Physicians
Nurses
Pharmacists
Clinical support
Administrative support (secretary, clerk, receptionist etc.)
Clinical manager
Quality manager
Risk manager
Patient Involvement
 
Direct service user's involvement as integral part of this Patient Safety Practice
No
Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice
There is no specified text here
Point of time in which service user or their reprasentatives' involvement takes place
There is no specified text here
Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice
There is no specified text here
Short description of the service users' level of involvement
There is no specified text here
Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users
Yes
List of sources where public information is accessible
http://buonepratiche.agenas.it/questionnaire.aspx?id=4969
Implementation of the Patient Safety Practice
 
Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice
No
Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc.
Yes
List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice
Other
List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice
There is no specified text here
Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice
No
Description of used incentives, if any.
There is no specified text here
Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice
Yes
Costs of the Patient Safety Practices
 
Completion of cost calculation related to this Patient Safety Practice
No
Total number of person days required to implement this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total number of person days required for training as preparation for implementation of this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice
There is no specified text here
Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice
There is no specified text here
Contact information
 
Name: Alessandra Zanardi, Anna Zuccheri, Giovanna Campaniello, Gianfranco Cervellin
Country: ITALY
Organisation: AZIENDA OSPEDALIERA DI PARMA
E-mail: azanardi@ao.pr.it
Phone: There is no specified text here
Print
Top
At la sikisen cesaretli kadina 50 cm at yarragi giriyor hayvanli porno izle
sirinevler escort sirinevler escort atakoy escort mecidiyekoy escort etiler escort atasehir escort capa escort
usak escort elazig escort
sex filme
porno
sirinevler escort beylikduzu escort atakoy escort sisli escort atakoy escort sisli escort sirinevler escort beylikduzu escort halkali escort halkali escort istanbul escort beylikduzu escort beylikduzu escort sirinevler escort sirinevler escort beylikd�z� escort �i�li escort �irinevler escort avrupa yakasi escort �apa escort beylikd�z� escort